Yubo International Biotech Limited (MAGAA) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access MAGAA Annual Balance Sheets →
From Yubo International Biotech Limited through Jun 30 2025, shifts in Jun 30 2026's assets and liabilities provide insight into the company's capital structure and financial stability.
Quarterly Report, GAAP in USD millions
ITEM
(Jun 30 2026)
(Mar 31 2026) (Dec 31 2025) (Sep 30 2025) (Jun 30 2025)
Assets
Cash & cash equivalent0.01
Security Deposit0.02
Cash & Short-term Investments0.00
Accounts receivable0.14
Inventories0.02
Other Current Assets0.00
Prepaid Expense, Current AS0.11
Total Current Assets0.58
Equipment/Property/Plant Net0.23
Intangible Assets0.04
Other Assets, Noncurrent0.10
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents0.01
Outstanding Balances With Affiliated Parties-
Operating Lease Right Of Use Asset-
Total Assets0.67
Liabilities
Accounts Payable1.31
Other Liabilities, Current2.02
Total Current Liabilities3.33
Total Long-term Debt0.00
Other liabilities, Noncurrent0.00
OperatingLeaseLiabilityNoncurrent-
Operating Lease Liability Current0.04
Total Liabilities3.33
Stockholders' Equity
Common Stock Value0.00
Additional Paid In Capital Common Stock5.47
Retained Earnings / Accumulated Deficit-8.26
Accumulated Other Comprehensive Income0.00
Other Equity0.00
Common Stockholder's Equity-2.66
Non-controlling interests & other0.00
Total Stockholder's Equity-2.66
Liabilities & Stockholder's Equity0.67
4 historic quarters locked

Sign in to unlock the full Yubo International Biotech Limited balance sheet history.

About Yubo International Biotech Ltd Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-Q filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

  • Form: 10-Q (Period: 20260630)
  • Filed with the SEC: August 14, 2026
  • Source: yubo_10q.htm

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001640334-26-001352

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.